When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. PMDD treatment: Doctors share remedies and medications that ...

    www.aol.com/pmdd-treatment-doctors-share...

    A lack of knowledge about PMDD can make it harder to get a diagnosis or effective treatment. ... Studies show SSRIs work for about 60–70% of PMDD patients, Ackerman adds. ... Ex-Ohio 911 ...

  3. Treatment and management of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Treatment_and_management...

    [52] [53] [54] As of July 2021, a large number of drugs had been considered for treating COVID-19 patients. [55] As of November 2022, there was moderate-certainty evidence suggesting that dexamethasone, and systemic corticosteroids in general, probably cause a slight reduction in all-cause mortality (up to 30 days) in hospitalized patients with ...

  4. Remdesivir - Wikipedia

    en.wikipedia.org/wiki/Remdesivir

    In order to ensure continued access to the pediatric population previously covered under the EUA, the FDA revised the EUA for remdesivir to authorize the drug's use for treatment of suspected or laboratory-confirmed COVID‑19 in hospitalized pediatric patients weighing 3.5 kilograms (7.7 lb) to less than 40 kilograms (88 lb) or hospitalized ...

  5. Molnupiravir - Wikipedia

    en.wikipedia.org/wiki/Molnupiravir

    [43] [16] In December 2021, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for molnupiravir for the treatment of mild-to-moderate COVID‑19 in adults with positive results of direct SARS-CoV-2 viral testing who are at high risk for progression to severe COVID‑19, including hospitalization or death, and ...

  6. Should you take a COVID-19 antiviral after getting infected ...

    www.aol.com/news/covid-19-antiviral-getting...

    “A brief return of symptoms may be part of the natural history of SARS-CoV-2 (the virus that causes COVID-19) infection in some persons, independent of treatment with Paxlovid and regardless of ...

  7. COVID-19 drug development - Wikipedia

    en.wikipedia.org/wiki/COVID-19_drug_development

    Bebtelovimab is a neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19.

  8. Ohio's COVID-19 case reports are spiking, but all aren't ...

    www.aol.com/ohios-covid-19-case-reports...

    Reported COVID-19 cases are up across Ohio in the past few weeks, but experts say the counts are still an underestimate of the actual virus cases. Ohio's COVID-19 case reports are spiking, but all ...

  9. Chloroquine and hydroxychloroquine during the COVID-19 ...

    en.wikipedia.org/wiki/Chloroquine_and_hydroxych...

    The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]